On the last day of bidding for the IPO of Medicamen Organics Limited, the issue received a tremendous response from the investors with the issue getting oversubscribed 993.56 times led by Non-institutional buyers (NII) who subscribed to the issue 1,343.83 times. Retail investors subscribed 1,309.77 times and Qualified institutions (QIB) subscribed 173.03 times, according to chittorgarh.com
The IPO that aims to raise Rs 10.54 crore through a fresh issue of 31 lakh shares, closed its subscription period on June 25. The bidding for the IPO began on June 21. The price band for the shares was set between Rs 32 and Rs 34 per share. Retail investors needed to invest a minimum of Rs 1,36,000 for 4,000 shares.
The allotment for Medicamen Organics IPO is expected to be finalised on Wednesday, June 26.
Investors can check Medicamen Organics IPO allotment status on official website of the registrar for IPO, Kfin Technologies Limited.
How to check Medicamen Organics IPO allotment status
Visit the Kfin Technologies website here: https://ris.kfintech.com/ipostatus/.
Click on any of the links displayed to view IPO Allotment Status.
Choose "Medicamen Organics Limited" from the drop-down list. (Name will be populated once the allotment is finalised).
Choose one of the three options: Application number, Demat Account number, or PAN ID.
Enter your application number or PAN or DPID.
Complete the 'captcha'.
Click "Submit" button.
View your allotment details.
Download/print the allotment status for your records.
Medicamen Organics IPO Listing Date
Shares of Medicamen Organics Limited are set to be listed on NSE SME on Friday, June 28.
Medicamen Organics IPO Timeline
IPO Open Date: Friday, June 21
IPO Close Date: Tuesday, June 25
Basis of Allotment: Wednesday, June 26
Initiation of Refunds: Thursday, June 27
Credit of Shares to Demat: Thursday, June 27
Listing Date: Friday, June 28
About Medicamen Organics Limited
Medicamen Organics Limited, founded in 1995, develops and manufactures various pharmaceutical products, including tablets, capsules, and syrups. They produce 84 different drugs, including antibiotics, antifungals, antimalarials, and diabetes medications, which they supply to both government and private entities as a contract manufacturer.
Their products are sold across India and in several African, CIS, and Southeast Asian countries through third-party distributors. The company operates two WHO-GMP-approved manufacturing facilities in Haridwar, Uttarakhand.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
